Peter Harwin

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Peter Harwin

Earlier roles on record: Board Member at Viridian Therapeutics, Inc.\DE (VRDN) until March 10, 2025. Viridian Therapeutics, Inc.\DE reported in an 8-K filed March 10, 2025 that Peter Harwin resigned as member of the Board, effective March 10, 2025.

“On March 5, 2025, Peter Harwin, a member of the Board, notified the Company of his decision to resign as a member of the Board effective as of March 10, 2025.”

Viridian Therapeutics, Inc.\DE Form 8-K, filed March 10, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Peter Harwin's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Viridian Therapeutics, Inc.\DE (VRDN)
Board Member

Proxy statement

Start not stated–2025-03-10

Company network

Recorded roles and call appearances connecting this person to public companies.

Viridian Therapeutics, Inc.\DE

VRDN

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: member of the Board Viridian Therapeutics, Inc.\DE (VRDN)
2025-03-10